Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002052113-25-002460·AVADEL PHARMACEUTICALS PLC
Schedule 13G ownership disclosure
AVADEL PHARMACEUTICALS PLC
Common Stock · CUSIP: G29687103
Event date: 2025-06-30
- Filing-level shares
- 6,742,480
- Percent of class
- 7.0%
- BlackRock, Inc.
Shares: 6,742,480 · Class: 7.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-002460
- Form type
- SCHEDULE 13G/A
- Filer
- AVADEL PHARMACEUTICALS PLC
- CIK
- CIK 1012477
- Filed
- Jul 16, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership